Home LiteratureArticle Details
PMID: 19596789 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

The tumor suppressor functions of p27(kip1) include control of the mesenchymal/amoeboid transition.

Molecular and cellular biology ·Vol. 29 ·No. 18 ·2009-09-00 ·Pages 5031-45

Berton S, Belletti B, Wolf K, Canzonieri V, Lovat F, Vecchione A, Colombatti A, Friedl P, Baldassarre G

Abstract

In many human cancers, p27 downregulation correlates with a worse prognosis, suggesting that p27 levels could represent an important determinant in cell transformation and cancer development. Using a mouse model system based on v-src-induced transformation, we show here that p27 absence is always linked to a more aggressive phenotype. When cultured in three-dimensional contexts, v-src-transformed p27-null fibroblasts undergo a morphological switch from an elongated to a rounded cell shape, accompanied by amoeboid-like morphology and motility. Importantly, the acquisition of the amoeboid motility is associated with a greater ability to move and colonize distant sites in vivo. The reintroduction of different p27 mutants in v-src-transformed p27-null cells demonstrates that the control of cell proliferation and motility represents two distinct functions of p27, both necessary for it to fully act as a tumor suppressor. Thus, we highlight here a new p27 function in driving cell plasticity that is associated with its C-terminal portion and does not depend on the control of cyclin-dependent kinase activity.

MeSH Terms
Animals Cell Line, Transformed Cell Movement Cell Proliferation Cell Shape Cyclin-Dependent Kinase Inhibitor p27/deficiency,metabolism Fibroblasts/cytology,metabolism Mesoderm/cytology,metabolism Mice Microtubules/metabolism Mutant Proteins/metabolism Neoplasms/pathology Oncogene Protein pp60(v-src)/metabolism Phenotype rhoA GTP-Binding Protein/metabolism
Chemicals
Mutant Proteins Cyclin-Dependent Kinase Inhibitor p27 Oncogene Protein pp60(v-src) rhoA GTP-Binding Protein
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Berton Stefania
Division of Experimental Oncology 2, Centro di Riferimento Oncologico, Aviano, Italy.
Belletti Barbara
Wolf Katarina
Canzonieri Vincenzo
Lovat Francesca
Vecchione Andrea
Colombatti Alfonso
Friedl Peter
Baldassarre Gustavo
References (52)
52 references, click to expand
  1. p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion.
    Cancer Cell. 2005 Jan;7(1):51-63 PMID: 15652749
  2. New dimensions in cell migration.
    Nat Cell Biol. 2003 Aug;5(8):690-2 PMID: 12894172
  3. Cdk5 phosphorylates and stabilizes p27kip1 contributing to actin organization and cortical neuronal migration.
    Nat Cell Biol. 2006 Jan;8(1):17-26 PMID: 16341208
  4. The Rac activator DOCK7 regulates neuronal polarity through local phosphorylation of stathmin/Op18.
    Neuron. 2006 Sep 21;51(6):727-39 PMID: 16982419
  5. TGFbeta-induced EMT requires focal adhesion kinase (FAK) signaling.
    Exp Cell Res. 2008 Jan 1;314(1):143-52 PMID: 17949712
  6. Downregulation of Skp2 and p27/Kip1 synergistically induces apoptosis in T98G glioblastoma cells.
    J Mol Med (Berl). 2005 Apr;83(4):296-307 PMID: 15605273
  7. Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product.
    Cancer Res. 1992 Sep 1;52(17):4773-8 PMID: 1380891
  8. A renaissance for SRC.
    Nat Rev Cancer. 2004 Jun;4(6):470-80 PMID: 15170449
  9. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.
    EMBO J. 1997 Sep 1;16(17):5334-44 PMID: 9311993
  10. Smurf1 regulates tumor cell plasticity and motility through degradation of RhoA leading to localized inhibition of contractility.
    J Cell Biol. 2007 Jan 1;176(1):35-42 PMID: 17190792
  11. Taking cell-matrix adhesions to the third dimension.
    Science. 2001 Nov 23;294(5547):1708-12 PMID: 11721053
  12. p27kip1 independently promotes neuronal differentiation and migration in the cerebral cortex.
    Genes Dev. 2006 Jun 1;20(11):1511-24 PMID: 16705040
  13. v-Src's hold over actin and cell adhesions.
    Nat Rev Mol Cell Biol. 2002 Apr;3(4):233-45 PMID: 11994743
  14. Localized stabilization of microtubules by integrin- and FAK-facilitated Rho signaling.
    Science. 2004 Feb 6;303(5659):836-9 PMID: 14764879
  15. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors.
    Cell. 1996 May 31;85(5):707-20 PMID: 8646779
  16. Novel p27(kip1) C-terminal scatter domain mediates Rac-dependent cell migration independent of cell cycle arrest functions.
    Mol Cell Biol. 2003 Jan;23(1):216-28 PMID: 12482975
  17. Tumour-cell invasion and migration: diversity and escape mechanisms.
    Nat Rev Cancer. 2003 May;3(5):362-74 PMID: 12724734
  18. Overexpressed cyclin D3 contributes to retaining the growth inhibitor p27 in the cytoplasm of thyroid tumor cells.
    J Clin Invest. 1999 Oct;104(7):865-74 PMID: 10510327
  19. The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis.
    Nat Cell Biol. 2007 Feb;9(2):218-24 PMID: 17237771
  20. Calpain 2 and Src dependence distinguishes mesenchymal and amoeboid modes of tumour cell invasion: a link to integrin function.
    Oncogene. 2006 Sep 21;25(42):5726-40 PMID: 16652152
  21. The rapamycin derivative RAD inhibits mesangial cell migration through the CDK-inhibitor p27KIP1.
    Lab Invest. 2004 May;84(5):588-96 PMID: 15064772
  22. The oncoprotein 18/stathmin family of microtubule destabilizers.
    Curr Opin Cell Biol. 2002 Feb;14(1):18-24 PMID: 11792540
  23. p27Kip1 modulates cell migration through the regulation of RhoA activation.
    Genes Dev. 2004 Apr 15;18(8):862-76 PMID: 15078817
  24. Role for p27(Kip1) in Vascular Smooth Muscle Cell Migration.
    Circulation. 2001 Jun 19;103(24):2967-72 PMID: 11413088
  25. The murine gene p27Kip1 is haplo-insufficient for tumour suppression.
    Nature. 1998 Nov 12;396(6707):177-80 PMID: 9823898
  26. Neutrophil microtubules suppress polarity and enhance directional migration.
    Proc Natl Acad Sci U S A. 2005 May 10;102(19):6884-9 PMID: 15860582
  27. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals.
    Cell. 1994 Jul 15;78(1):59-66 PMID: 8033212
  28. p27Kip1 expression inhibits glioblastoma growth, invasion, and tumor-induced neoangiogenesis.
    Mol Cancer Ther. 2008 May;7(5):1164-75 PMID: 18483304
  29. Newest findings on the oldest oncogene; how activated src does it.
    J Cell Sci. 2004 Mar 1;117(Pt 7):989-98 PMID: 14996930
  30. Expression of pp60c-src in human small cell and non-small cell lung carcinomas.
    Eur J Cancer. 1992;28(2-3):372-7 PMID: 1375484
  31. Prespecification and plasticity: shifting mechanisms of cell migration.
    Curr Opin Cell Biol. 2004 Feb;16(1):14-23 PMID: 15037300
  32. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation.
    Genes Dev. 1999 May 1;13(9):1181-9 PMID: 10323868
  33. Overexpression and activation of the tyrosine kinase Src in human pancreatic carcinoma.
    Biochem Biophys Res Commun. 1998 Feb 13;243(2):503-8 PMID: 9480838
  34. Activating SRC mutation in a subset of advanced human colon cancers.
    Nat Genet. 1999 Feb;21(2):187-90 PMID: 9988270
  35. Expression of the v-Src oncoprotein in fibroblasts disrupts normal regulation of the CDK inhibitor p27 and inhibits quiescence.
    Oncogene. 1998 Apr 16;16(15):2017-28 PMID: 9591786
  36. Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis.
    J Cell Biol. 2003 Jan 20;160(2):267-77 PMID: 12527751
  37. p27(kip1) functional regulation in human cancer: a potential target for therapeutic designs.
    Curr Med Chem. 2005;12(14):1589-605 PMID: 16022660
  38. Loss of p53 promotes RhoA-ROCK-dependent cell migration and invasion in 3D matrices.
    J Cell Biol. 2007 Jul 2;178(1):23-30 PMID: 17606864
  39. Endocytic trafficking of Rac is required for the spatial restriction of signaling in cell migration.
    Cell. 2008 Jul 11;134(1):135-47 PMID: 18614017
  40. Overexpression of p27(Kip1) by doxycycline-regulated adenoviral vectors inhibits endothelial cell proliferation and migration and impairs angiogenesis.
    FASEB J. 2001 Sep;15(11):1877-85 PMID: 11532967
  41. The cyclin-dependent kinase inhibitors p57 and p27 regulate neuronal migration in the developing mouse neocortex.
    J Biol Chem. 2007 Jan 5;282(1):390-6 PMID: 17092932
  42. Antitumour effect of cyclin-dependent kinase inhibitors (p16(INK4A), p18(INK4C), p19(INK4D), p21(WAF1/CIP1) and p27(KIP1)) on malignant glioma cells.
    Br J Cancer. 2003 Apr 22;88(8):1277-80 PMID: 12698196
  43. Cancer. Respect thy neighbor!
    Science. 2004 Feb 6;303(5659):775-7 PMID: 14764858
  44. Src in cancer: deregulation and consequences for cell behaviour.
    Biochim Biophys Acta. 2002 Jun 21;1602(2):114-30 PMID: 12020799
  45. Integrins and cell proliferation: regulation of cyclin-dependent kinases via cytoplasmic signaling pathways.
    J Cell Sci. 2001 Jul;114(Pt 14):2553-60 PMID: 11683383
  46. G1 phase progression: cycling on cue.
    Cell. 1994 Nov 18;79(4):551-5 PMID: 7954821
  47. p27(Kip1) enhances myelin basic protein gene promoter activity.
    J Neurosci Res. 2002 Jan 1;67(1):100-5 PMID: 11754085
  48. Stathmin activity influences sarcoma cell shape, motility, and metastatic potential.
    Mol Biol Cell. 2008 May;19(5):2003-13 PMID: 18305103
  49. Molecular mechanisms of cancer cell invasion and plasticity.
    Br J Dermatol. 2006 May;154 Suppl 1:11-5 PMID: 16712711
  50. Putting tumours in context.
    Nat Rev Cancer. 2001 Oct;1(1):46-54 PMID: 11900251
  51. Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis.
    Nat Cell Biol. 2003 Aug;5(8):711-9 PMID: 12844144
  52. The mechanism of cell cycle regulation by v-Src.
    Oncogene. 2001 Sep 20;20(42):5941-50 PMID: 11593401
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
1098-5549
Published
2009-09-00
Epub
2009-00-13
Pages
5031-45
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC2738297
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com